Clinical trial

Januvia Re-examination Study (MK-0431-181)

NCT01062048

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date2008-10-01

PhaseN/A

Study timeline

Study start (unknown)2008-10-01Date precision: month

Registry last updated2016-02-05

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Type 2 Diabetes Mellitusverified · MONDO: type 2 diabetes mellitus

Interventions

SitagliptinDRUG · verified · RxNorm: sitagliptin

SulfonylureaDRUG

InsulinBIOLOGICAL

Sponsors & collaborators

Merck Sharp & Dohme LLClead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01062048 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.